Hormone-Peptide Conjugates: Next Generation Targeted Therapy
Time: 10:30 am
day: Day Two
Details:
- Exploring a paradigm shift in conjugate design, focusing on the mechanism rather than the molecule, to unlock new avenues for targeted therapy innovations
- Embracing innovation, this conjugate design bypasses traditional linker-based approaches, with the hormone directly fused to the lytic peptide, optimizing delivery and enhancing therapeutic efficacy
- Understanding how the unique design of hormone-linked lytic peptides, leveraging electrostatic interactions for targeted cytotoxicity, offers a safer and more effective approach to cancer therapy
